BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23990207)

  • 1. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification.
    Callegari A; Coons ML; Ricks JL; Yang HL; Gross TS; Huber P; Rosenfeld ME; Scatena M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2491-500. PubMed ID: 23990207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
    Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
    PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.
    Bennett BJ; Scatena M; Kirk EA; Rattazzi M; Varon RM; Averill M; Schwartz SM; Giachelli CM; Rosenfeld ME
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2117-24. PubMed ID: 16840715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
    Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
    J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice.
    Bentzon JF; Weile C; Sondergaard CS; Hindkjaer J; Kassem M; Falk E
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2696-702. PubMed ID: 17008593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report.
    Ovchinnikova O; Gylfe A; Bailey L; Nordström A; Rudling M; Jung C; Bergström S; Waldenström A; Hansson GK; Nordström P
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1478-80. PubMed ID: 19592469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification.
    Chasseraud M; Liabeuf S; Mozar A; Mentaverri R; Brazier M; Massy ZA; Kamel S
    Ther Apher Dial; 2011 Apr; 15(2):140-6. PubMed ID: 21426505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo.
    Candido R; Toffoli B; Corallini F; Bernardi S; Zella D; Voltan R; Grill V; Celeghini C; Fabris B
    J Vasc Res; 2010; 47(3):252-61. PubMed ID: 19907187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice.
    Sasaki T; Nakamura K; Sasada K; Okada S; Cheng XW; Suzuki T; Murohara T; Sato K; Kuzuya M
    Atherosclerosis; 2013 Mar; 227(1):43-50. PubMed ID: 23312504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
    Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis.
    Preusch MR; Rattazzi M; Albrecht C; Merle U; Tuckermann J; Schütz G; Blessing E; Zoppellaro G; Pauletto P; Krempien R; Rosenfeld ME; Katus HA; Bea F
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2158-64. PubMed ID: 18787189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
    Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shift of Macrophage Phenotype Due to Cartilage Oligomeric Matrix Protein Deficiency Drives Atherosclerotic Calcification.
    Fu Y; Gao C; Liang Y; Wang M; Huang Y; Ma W; Li T; Jia Y; Yu F; Zhu W; Cui Q; Li Y; Xu Q; Wang X; Kong W
    Circ Res; 2016 Jul; 119(2):261-76. PubMed ID: 27151399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.
    Sandberg WJ; Yndestad A; Øie E; Smith C; Ueland T; Ovchinnikova O; Robertson AK; Müller F; Semb AG; Scholz H; Andreassen AK; Gullestad L; Damås JK; Frøland SS; Hansson GK; Halvorsen B; Aukrust P
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):857-63. PubMed ID: 16424351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice.
    George J; Afek A; Abashidze A; Shmilovich H; Deutsch V; Kopolovich J; Miller H; Keren G
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2636-41. PubMed ID: 16195475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.